Medicare Enrolled

Dr. Howard Natter, MD

Optician · Meadowbrook, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1650 HUNTINGDON PIKE, Meadowbrook, PA 19046
2159387730
In practice since 2006 (20 years)
NPI: 1578529210 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Natter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Natter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Natter

Dr. Howard Natter is an optician specialist in Meadowbrook, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Natter performed 1,182 Medicare services across 951 unique beneficiaries.

Between the years covered by Open Payments, Dr. Natter received a total of $16,176 from 84 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Natter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in PA $16,176 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,182
Medicare services
Top 27% in PA for optician
951
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
698 $80 $275
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
183 $116 $350
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
180 $106 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $53 $190
New patient office visit, complex (60-74 min) 48 $148 $425
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,176
Total received (2018-2024)
Avg $2,311/year across 7 years
Top 11% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,687 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$489 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,353
2023
$2,115
2022
$2,326
2021
$2,161
2020
$1,457
2019
$2,879
2018
$3,885

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$181
ACADIA Pharmaceuticals Inc
$132
E.R. Squibb & Sons, L.L.C.
$125
ABBVIE INC.
$101
ARGENX US, INC.
$96
TG Therapeutics, Inc.
$66
Avadel CNS Pharmaceuticals, LLC
$65
Alexion Pharmaceuticals, Inc.
$65
Lilly USA, LLC
$63
Genentech USA, Inc.
$51
Lundbeck LLC
$48
HARMONY BIOSCIENCES LLC
$44
Novartis Pharmaceuticals Corporation
$43
JAZZ PHARMACEUTICALS INC.
$37
UCB, Inc.
$35
CSL Behring
$34
Axsome Therapeutics, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Alnylam Pharmaceuticals Inc.
$23
Eisai Inc.
$23
PFIZER INC.
$20
Amgen Inc.
$20
Azurity Pharmaceuticals, Inc.
$17
Top 3 companies account for 32.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,283
Teva Pharmaceuticals USA, Inc.
$1,064
Biogen, Inc.
$1,022
EMD Serono, Inc.
$940
UCB, Inc.
$932
Abbott Laboratories
$770
Alexion Pharmaceuticals, Inc.
$685
GENZYME CORPORATION
$588
Genentech USA, Inc.
$479
Amgen Inc.
$423
ACADIA Pharmaceuticals Inc
$376
Lilly USA, LLC
$356
JAZZ PHARMACEUTICALS INC.
$353
Medtronic USA, Inc.
$337
Lundbeck LLC
$329
ARGENX US, INC.
$302
Janssen Pharmaceuticals, Inc
$301
SK Life Science, Inc.
$296
ABBVIE INC.
$279
Adamas Pharmaceuticals, Inc.
$266
US WorldMeds, LLC
$260
Allergan Inc.
$244
E.R. Squibb & Sons, L.L.C.
$240
Acorda Therapeutics, Inc
$231
Avanir Pharmaceuticals, Inc.
$212
Eisai Inc.
$210
Amneal Pharmaceuticals LLC
$185
PFIZER INC.
$183
Jazz Pharmaceuticals Inc.
$181
AbbVie Inc.
$175
Sunovion Pharmaceuticals Inc.
$142
Biohaven Pharmaceuticals, Inc.
$128
Celgene Corporation
$124
CSL Behring
$114
Nevro Corp.
$98
Arbor Pharmaceuticals, Inc.
$95
HARMONY BIOSCIENCES LLC
$92
TG THERAPEUTICS, INC.
$90
Biohaven Pharmaceutical Holding Company Ltd.
$87
ARBOR PHARMACEUTICALS, INC.
$82
Supernus Pharmaceuticals, Inc.
$81
Upsher-Smith Laboratories LLC
$76
Sumitomo Pharma America, Inc.
$75
Boston Scientific Corporation
$71
Avion Pharmaceuticals
$71
TG Therapeutics, Inc.
$66
Avadel CNS Pharmaceuticals, LLC
$65
Grifols USA, LLC
$61
PORTOLA PHARMACEUTICALS, INC.
$61
Promius Pharma LLC
$59
Kyowa Kirin, Inc.
$54
Neurelis, Inc.
$52
Banner Life Sciences, LLC
$46
MDD US Operations, LLC
$46
Harmony Biosciences LLC
$42
Mitsubishi Tanabe Pharma America, Inc.
$42
PORTOLA PHARMACEUTICALS, LLC
$41
Mallinckrodt Enterprises LLC
$40
Aprecia Pharmaceuticals, LLC
$34
Otsuka America Pharmaceutical, Inc.
$34
Axsome Therapeutics, Inc.
$32
Allergan, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
UPSHER-SMITH LABORATORIES LLC
$28
Vertical Pharmaceuticals, LLC
$28
Mylan Pharmaceuticals Inc.
$28
Shire North American Group Inc
$25
AbbVie, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
Mallinckrodt LLC
$23
GE HealthCare
$22
BOSTON SCIENTIFIC CORPORATION
$21
Corium, LLC
$20
Bausch Health US, LLC
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
Neurocrine Biosciences, Inc.
$19
Azurity Pharmaceuticals, Inc.
$17
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Strongbridge US INC.
$16
Ipsen Biopharmaceuticals, Inc
$15
Merz North America, Inc.
$14
AQUESTIVE THERAPEUTICS, INC.
$13
Impax Laboratories, Inc.
$13
Piramal Imaging Limited
$8
Top 3 companies account for 20.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Aimovig · BAFIERTAM · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · Deep Brain Stimulation · Dhivy · Dysport · EMGALITY · Edarbi · Enspryng · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUMRYZ · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · OCREVUS · ONFI · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUNOSI · SYMPAZAN · Senza · Senza Spinal Cord Stimulation System · Soliris · Spritam · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Meadowbrook?
Compare opticians in the Meadowbrook area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
729
Per 100K population
84.6
County median income
$111,521
Nearest hospital
HOLY REDEEMER HOSPITAL AND MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Natter is a clinical cardiology specialist, with above-average Medicare volume (top 27% in PA), with low-engagement industry engagement in the top 11% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Natter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Natter performed 698 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Natter receive payments from pharmaceutical companies?
Yes. Dr. Natter received a total of $16,176 from 84 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Natter's costs compare to other opticians in Meadowbrook?
Dr. Natter's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Natter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →